PMID: 6986133Jan 1, 1980Paper

Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study

Archives of General Psychiatry
A WinokurN J Schatz

Abstract

Symptoms of diazepam withdrawal developed in a young man who had been taking diazepam in dosages of 15 to 25 mg/day during a six-year period. This was verified in a study conducted under placebo-controlled, double blind conditions, with plasma levels of diazepam and its major metabolite, desmethyldiazepam, monitored throughout the course of the study. Severe symptoms of physiological withdrawal were observed within two days of replacement of diazepam with placebo capsules. The patient recovered promptly on reinstitution of diazepam administration, and relapsed during a second withdrawal phase. During an additional two week-period of placebo administration, the patient's condition first worsened, then gradually improved. Examination of plasma levels of diazepam and desmethyldiazepam indicated no obvious pharmacokinetic abnormalities. Thus, with long-term administration of diszepam, even in therapeutically accepted doses, withdrawal reactions can be encountered on abrupt termination.

Citations

Jul 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·J S DuncanM R Trimble
May 11, 1985·British Medical Journal·J Catalan, D H Gath
Apr 14, 1984·British Medical Journal·P J Tyrer
Jan 1, 1991·Journal of Substance Abuse Treatment·B Alexander, P J Perry
Jan 1, 1991·Journal of Substance Abuse Treatment·H Ashton
Jan 1, 1997·Progress in Neuro-psychopharmacology & Biological Psychiatry·P Lemoine, M M Ohayon
Jan 1, 1990·Journal of Psychiatric Research·D J Nutt
Jan 1, 1982·Journal of Psychiatric Research·A K ShapiroB I Milcarek
Jan 1, 1989·European Archives of Psychiatry and Neurological Sciences·B GeiselmannN Sachs-Ericsson
May 1, 1990·Journal of Affective Disorders·P TyrerP Riley
Sep 1, 1987·Journal of Affective Disorders·R P SwinsonM E Kirby
Jan 1, 1990·Pharmacology & Therapeutics·D J Nutt
Jan 1, 1982·The American Journal of Drug and Alcohol Abuse·G L MacKinnon, W A Parker
Sep 1, 1987·Medical Toxicology and Adverse Drug Experience·C F George, D Robertson
Oct 1, 1980·Psychosomatics·K Rickels
Oct 1, 1980·Psychosomatics·F J Ayd
Feb 15, 2011·Journal of Anxiety Disorders·Francisco López-MuñozPilar García-García
Dec 1, 1995·Critical Care Medicine·M A MirskiD F Hanley
Mar 19, 1990·Brain Research·C A MariettaF F Weight
Apr 1, 1982·Drug and Alcohol Dependence·J W HawthorneB C D'Lugoff
Mar 1, 1985·Journal of Clinical Pharmacology·E O BixlerC R Soldatos
Jun 1, 1986·Alcoholism, Clinical and Experimental Research·C A MariettaF F Weight
Jan 1, 1990·Neuroscience and Biobehavioral Reviews·S E File
Aug 1, 1986·Annals of Emergency Medicine·J M Ellison, D Jacobs
Aug 18, 1983·The New England Journal of Medicine·D J GreenblattD R Abernethy
Oct 2, 1986·The New England Journal of Medicine·U BustoK Sykora
Jan 1, 1983·Journal of Psychoactive Drugs·D E Smith, D R Wesson
Jan 1, 1983·Journal of Psychoactive Drugs·K Rickels
Jan 1, 1983·Journal of Psychoactive Drugs·J H Woods
Nov 1, 1990·The Journal of Psychology·J B Murray
Jun 1, 1981·The Australian and New Zealand Journal of Psychiatry·F A Whitlock
Jul 16, 2008·Journal of Clinical Psychopharmacology·Karl RickelsGeorge W Case
Sep 27, 2018·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Karl Rickels, Hans Juergen Moeller
Feb 6, 2019·International Journal of Environmental Research and Public Health·Angelo G I MaremmaniIcro Maremmani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.